• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
[Ala19]-Glucagon-like Peptide II, rat

[Ala19]-Glucagon-like Peptide II, rat

Product ID G4485
Cas No. 89750-15-2
Purity ≥95%
Product Unit SizeCostQuantityStock
0.5 mg $225.80 Please Inquire
1 mg $393.80 Please Inquire
2.5 mg $787.50 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Glucagon-like peptide 2 (GLP-2) is a peptide hormone primarily synthesized in the intestine and pancreas. GLP-2 binds and activates the GLP-2 receptor, exhibiting vasodilatory, antihypertensive, antidepressant, and gastrointestinal motility modulating activities. In animal models, GLP-2 increases intestinal blood flow and decreases mean arterial blood pressure. GLP-2 potentiates L-type voltage-gated Ca2+ channels through a mechanism that involves activation of PKA. Additionally, GLP-2 decreases immobility time in animals undergoing the forced swim test. This peptide stimulates cell proliferation, inhibiting chemotherapy-induced mucosal atrophy in the intestines. GLP-2 also decreases gastric emptying and gastrointestinal motility.

Product Info

Cas No.

89750-15-2

Purity

≥95%

Formula

C165H254N44O55S

Formula Wt.

3766.2

Synonym

GLP-2

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G4485 MSDS PDF

Info Sheet

G4485 Info Sheet PDF

References

Sasaki-Hamada S, Ito K, Oka JI. Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2. Life Sci. 2013 Oct 24. pii: S0024-3205(13)00618-8. [Epub ahead of print]. PMID: 24513200.

Hansen LB. GLP-2 and mesenteric blood flow. Dan Med J. 2013 May;60(5):B4634. PMID: 23673268.

Rasmussen AR, Viby NE, Hare KJ, et al. The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin. Dig Dis Sci. 2010 Oct;55(10):2785-96. PMID: 20112065.

Wang Y, Guan X. GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E156-66. PMID: 19920220.

Iwai T, Hayashi Y, Narita S, et al. Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res. 2009 Dec 1;204(1):235-40. PMID: 19539656.

Mojsov S, Kopczynski MG, Habener JF. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem. 1990 May 15;265(14):8001-8. PMID: 1692320.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G7232

    GS-9973

    Syk inhibitor.
    ≥98%
  • Y4802

    YM-201636

    PIKfyve inhibitor.
    ≥98%
  • A9801

    Azaperone

    Butyrophenone; α-adrenergic, D2, histamine antago...
    ≥98%
  • T7197

    Tryprostatin A

    Diketopiperazine produced by Aspergillus; microtub...
    ≥92%
  • S0170

    Sarafloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial DN...
    ≥91%
  • P0008

    Pituitary Adenylate Cyclase-activating Peptide (6-38), human/sheep/rat

    Endogenous peptide, involved in paracrine and auto...
    ≥95%
  • D0006

    Dacomitinib Monohydrate

    EGFR inhibitor.
    ≥99%
  • B6959

    Bromosporine

    BRD2/4/9 and CECR2 inhibitor.
    ≥99%
  • L3561

    D,L-α-Lipoic Acid

    Endogenous organosulfur also found in meat and veg...
    ≥98%
  • G4597

    18β-Glycyrrhetinic Acid

    Triterpene glycoside found in Glycyrrhiza; 15-HPGD...
    ≥98%
  • P3456

    Pimobendan

    PDE3 inhibitor.
    ≥98%
  • M1979

    Methyl Salicylate

    Ester found in Spiraea, Betula, and Gaultheria; TR...
    ≥98%
  • C3214

    CID-797718

    Potential PKD binding agent.
    ≥99%
  • C5646

    Collagen Binding Fragment

    Peptide, fibronectin fragment, used as fibronectin...
    ≥95%
  • M1778

    S-(+)-α−Methylbenzyl Isothiocyanate

    ITC, used as chiral agent.
    ≥98%
  • V3251

    Vinorelbine Base

    Semi-synthetic vinca alkaloid found in Catharanthu...
    ≥90%
  • V0269

    Vardenafil Dihydrochloride

    PDE5 inhibitor.
    ≥98%
  • P0276

    Peptide 401

    Antimicrobial peptide found in bee and wasp venom.
    ≥95%
  • L1616

    LEE-011

    CDK4/6 inhibitor.
    ≥98%
  • V1854

    Venlafaxine Hydrochloride

    SERT, NET, MAO inhibitor.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only